William Guyer Corcept Therapeutics Inc (CORT) insider trading activity

CORT Quotes by TradingView

William Guyer is Chief Development Officer of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 5,796 shares of CORT, which is worth approximately $283,830. The most recent transaction as insider was on Oct 01, 2024, when has been sold 10,000 shares (Common Stock) at a price of $46.28 per share, resulting in proceeds of $462,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.8K
4.02% 3M change
0.91% 12M change
Total Value Held $283,830

William Guyer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2024
SELL
Open market or private sale
$462,800 $46.28 p/Share
10,000 Reduced 63.31%
5,796 Common Stock
Oct 01 2024
BUY
Exercise of conversion of derivative security
$216,500 $21.65 p/Share
10,000 Added 38.77%
15,796 Common Stock
Sep 03 2024
SELL
Payment of exercise price or tax liability
$8,577 $35.3 p/Share
243 Reduced 4.02%
5,796 Common Stock
Sep 03 2024
SELL
Open market or private sale
$353,000 $35.3 p/Share
10,000 Reduced 62.35%
6,039 Common Stock
Sep 03 2024
BUY
Exercise of conversion of derivative security
$216,500 $21.65 p/Share
10,000 Added 38.4%
16,039 Common Stock
Aug 01 2024
SELL
Open market or private sale
$386,700 $38.67 p/Share
10,000 Reduced 62.35%
6,039 Common Stock
Aug 01 2024
BUY
Exercise of conversion of derivative security
$216,500 $21.65 p/Share
10,000 Added 38.4%
16,039 Common Stock
Jul 01 2024
SELL
Open market or private sale
$324,900 $32.49 p/Share
10,000 Reduced 62.35%
6,039 Common Stock
Jul 01 2024
BUY
Exercise of conversion of derivative security
$216,500 $21.65 p/Share
10,000 Added 38.4%
16,039 Common Stock
Jun 03 2024
SELL
Open market or private sale
$320,000 $32.0 p/Share
10,000 Reduced 62.35%
6,039 Common Stock
Jun 03 2024
BUY
Exercise of conversion of derivative security
$192,600 $19.26 p/Share
10,000 Added 38.4%
16,039 Common Stock
May 28 2024
SELL
Open market or private sale
$960,000 $32.0 p/Share
30,000 Reduced 83.24%
6,039 Common Stock
May 28 2024
BUY
Exercise of conversion of derivative security
$577,800 $19.26 p/Share
30,000 Added 45.43%
36,039 Common Stock
Mar 01 2024
SELL
Payment of exercise price or tax liability
$14,532 $24.06 p/Share
604 Reduced 9.09%
6,039 Common Stock
Dec 22 2023
SELL
Open market or private sale
$320,000 $32.0 p/Share
10,000 Reduced 60.09%
6,643 Common Stock
Dec 22 2023
BUY
Exercise of conversion of derivative security
$192,600 $19.26 p/Share
10,000 Added 37.53%
16,643 Common Stock
Dec 01 2023
BUY
Grant, award, or other acquisition
$15,821 $12.99 p/Share
1,218 Added 15.49%
6,643 Common Stock
Sep 01 2023
BUY
Grant, award, or other acquisition
$15,821 $16.55 p/Share
956 Added 14.27%
5,744 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
$29,233 $9.93 p/Share
2,944 Added 38.08%
4,788 Common Stock
Sep 01 2022
BUY
Grant, award, or other acquisition
$23,954 $12.99 p/Share
1,844 Added 50.0%
1,844 Common Stock
WG

William Guyer

Chief Development Officer
Menlo Park, CA

Track Institutional and Insider Activities on CORT

Follow CORCEPT THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

News

Receive news related to CORCEPT THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CORT